← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 9, 1990Last known activity
Dec 22, 2015
Timeline
1960s
- Jan 1, 1968
Radiation Therapy Oncology Group— Founded
Drugs by trial phase (94 distinct, 143 trials)
Phase 3 (58 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenocarcinoma of Lung
- Anus Neoplasms
- Astrocytoma
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Central Nervous System Neoplasms
- Colorectal Neoplasms
- Cystadenocarcinoma, Serous
- Deglutition Disorders
- Diarrhea
- Drug-Related Side Effects and Adverse Reactions
- Endometrial Neoplasms
- Enteritis
- Erectile Dysfunction
- Esophageal Neoplasms
- Esophagitis
- Fibrosis
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Glioma
- Gliosarcoma
- Head and Neck Neoplasms
- Laryngeal Diseases
- Laryngeal Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Mucositis
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Neurotoxicity Syndromes
- Oligodendroglioma
- Oropharyngeal Neoplasms
- Osteoporosis
- Pancreatic Neoplasms
- Pleural Effusion
- Pleural Effusion, Malignant
- Precancerous Conditions
- Prostatic Neoplasms
- Radiation Pneumonitis
- Rectal Neoplasms
- Salivary Gland Neoplasms
- Sarcoma
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stomatitis
- Tongue Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Xerostomia
Recent trials (50)
- NCT02573324CollaboratorPhase 2Dec 22, 2015
- NCT02179086CollaboratorPhase 2Nov 1, 2014
- NCT01993810Lead sponsorPhase 3Feb 1, 2014
- NCT01993810Overall official - principal investigatorPhase 3Feb 1, 2014
- NCT01953952Lead sponsorPhase 2Dec 1, 2013
- NCT01953952Overall official - principal investigatorPhase 2Dec 1, 2013
- NCT02075112CollaboratorPhase 1Nov 1, 2013
- NCT01921751Lead sponsorPhase 2Aug 1, 2013
- NCT01730937Lead sponsorPhase 3Apr 1, 2013
- NCT01730937Overall official - principal investigatorPhase 3Apr 1, 2013
- NCT01810913Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2013
- NCT01810913Lead sponsorPhase 2/Phase 3Mar 1, 2013
- NCT01730950Lead sponsorPhase 2Dec 1, 2012
- NCT01711658Lead sponsorPhase 2Nov 1, 2012
- NCT01546987Lead sponsorPhase 3May 1, 2012
Details
- Founded
- Philadelphia, PA, US Jan 1, 1968
- Last known activity
- Dec 22, 2015
Notes
RTOG is a participant in National Cancer Institute research through NRG Oncology.